Draft clinical study reports from approved material

Source checkedPharmaceuticalsEurope

Novo Nordisk uses Claude in NovoScribe to draft clinical documentation from expert-approved text and study-specific variables. Claude Code helped build the platform. The company reports 90% less writing time for clinical study reports; human review and approval remain part of the process.

Source checked: the source link is valid and the automated fact check passed. The summary is AI-assisted. This is not human verification. Check the original source before relying on its claims.

For whom

Medical writers at large pharmaceutical companies; clinical and regulatory expertise plus integration support.

Not for

Not suitable for generating final regulatory submissions without expert review.

Brain Score

4/10 brain cellsas of
Impact
1/2
Evidence
1/2
Reproducibility
0/2
Maturity
2/2
Reach
0/2

Five values from 0 to 2. The total has a minimum of 1. A reading aid based on the source, not an independently measured performance result. How the score works

Still current?

Current

Today: NovoScribe still combines approved text and study data using Claude on Bedrock to draft reports for expert review and approval.

Augments or replaces?

Augments your skills

Experts retain responsibility for clinical interpretation, review and approval, while AI drafts reports from approved source material.

Original source

Novo Nordisk accelerates clinical documentation and drug development with Claude 
Type
Vendor
Published
Data as of

The data date records when this dataset was included in the collection. It is separate from the publication date of the source.

Tools

All use cases